R. Hector MacKay-Dunn is Director at Aurinia Pharmaceuticals Inc. (AUPH). They have made 4 open-market trades across 1 company since 2021, most recently 2024-05-21.
CIK 0001838521
2 open-market purchases totalling $106K since 2021, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AUPH | 18,595 | $319K |
Shares reported on the most recent Form 4, priced at the 2024-05-22 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.